CBS Mornings | Weight loss drugs could help patients struggling with addiction, study says @CBSMornings | Uploaded October 2024 | Updated October 2024, 2 days ago.
A new study shows diabetes drugs like Mounjaro and Ozempic, which people also take to lose weight, may help patients suffering from addiction. CBS News contributor Dr. Celine Gounder explains.
Each weekday morning, "CBS Mornings" co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.
Subscribe to "CBS Mornings" on YouTube: youtube.com/CBSMornings
Watch CBS News 24/7: cbsnews.com/live
Download the CBS News app: cbsnews.com/mobile
Follow "CBS Mornings" on Instagram: instagram.com/cbsmornings
Like "CBS Mornings" on Facebook: facebook.com/CBSMornings
Follow "CBS Mornings" on X: twitter.com/CBSMornings
Subscribe to our newsletter: cbsnews.com/newsletters
Try Paramount+ free: paramountplus.com/?ftag=PPM-05-10aeh8h
For video licensing inquiries, contact: licensing@veritone.com
A new study shows diabetes drugs like Mounjaro and Ozempic, which people also take to lose weight, may help patients suffering from addiction. CBS News contributor Dr. Celine Gounder explains.
Each weekday morning, "CBS Mornings" co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.
Subscribe to "CBS Mornings" on YouTube: youtube.com/CBSMornings
Watch CBS News 24/7: cbsnews.com/live
Download the CBS News app: cbsnews.com/mobile
Follow "CBS Mornings" on Instagram: instagram.com/cbsmornings
Like "CBS Mornings" on Facebook: facebook.com/CBSMornings
Follow "CBS Mornings" on X: twitter.com/CBSMornings
Subscribe to our newsletter: cbsnews.com/newsletters
Try Paramount+ free: paramountplus.com/?ftag=PPM-05-10aeh8h
For video licensing inquiries, contact: licensing@veritone.com